
NAD+-Boosting Supplements May Help Pancreatic Cancer Survive Chemotherapy
A Case Western Reserve University study suggests over-the-counter NAD+-boosting derivatives NMN, NR, and NAM may enable pancreatic cancer cells to withstand chemotherapy (oxaliplatin, 5-fluorouracil, gemcitabine) in lab and animal tests. While NAD+ boosts can benefit healthy cells, cancer cells may gain energy to repair chemo damage, prompting caution for patients undergoing treatment and routine screening of supplement use by oncology teams; findings are not yet proven in humans and more research is needed.












